Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Oceanison Mar 09, 2023 12:17am
113 Views
Post# 35327416

RE:They’re loading up and doing small trades to keep “price low

RE:They’re loading up and doing small trades to keep “price lowyep, they keep passing it around, cycles of accumulate and dump, rinse and repeat, everyone gets repeated kicks at the can - maintain a ridiculously low share price like an endless pyramid scheme.

And then digging in the other Lp pocket, the provincial and federal goverments hands - excessive taxing and 'distributon' markups.  Mandatory - no direct to retail sell-through.  Can you say monopolize.  All the while refusing to police the illicit market which was the whole point of it in the first place.  Or so they said.

But wait, n worries at all, the federal government has given Lp's seven-more-months to decide what products they're going to sell within the new cannabis tax reform!  A year late it is this reform, so really, almost 2 yrs late when all is said and done/september.  Talk about a fleece job.  


 
 
 
 
 
 
 
In 2021-2022 alone, gov't cannabis revenue was $1.6 billion:
—$300 million profit for province-owned cannabis authorities
—$200 million in federal excise tax
—$600 million from provincial excise tax & other provincial or territorial revenue
—$500 million from retail sales tax

...One things' for sure - is that the lp's that make it through the gauntlet - will have become battle.hardened.strong - there is no doubt.

Medipharms cash position guarantees they'll make it through, but likely sell us out in the end.

Longs be damned!

..Right before a major contract or major Q, of course.



 

<< Previous
Bullboard Posts
Next >>